Order Article Reprints

Krome AK, Becker T, Kehraus S, Schiefer A, Steinebach C, Aden T, Frohberger SJ, López Mármol Á, Kapote D, Jansen R, et al. Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics. 2020; 12(11):1105. https://doi.org/10.3390/pharmaceutics12111105

Krome, Anna K., Tim Becker, Stefan Kehraus, Andrea Schiefer, Christian Steinebach, Tilman Aden, Stefan J. Frohberger, Álvaro López Mármol, Dnyaneshwar Kapote, Rolf Jansen, and et al. 2020. "Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A" Pharmaceutics 12, no. 11: 1105. https://doi.org/10.3390/pharmaceutics12111105

Krome, A. K., Becker, T., Kehraus, S., Schiefer, A., Steinebach, C., Aden, T., Frohberger, S. J., López Mármol, Á., Kapote, D., Jansen, R., Chaverra-Muñoz, L., Hübner, M. P., Pfarr, K., Hesterkamp, T., Stadler, M., Gütschow, M., König, G. M., Hoerauf, A., & Wagner, K. G. (2020). Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics, 12(11), 1105. https://doi.org/10.3390/pharmaceutics12111105